← Leaderboards
Sang Hyun Cho
University Of Texas Hlth Sci Ctr Houston
$5,825,687
Attributed
$9,486,098
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,486,098 · 4
By mechanism
R01$9,486,098 · 4
Top collaborators
- Sunil Krishnan14 shared
- Konstantin V Sokolov4 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Sunil Krishnan$6,566,279
- Giridhar Padmanabhan Kalamangalam$1,401,845
- Yi-Ping Li$13,186,933
- Syed H Jafri$1,347,401
- David W Marshak$4,680,132
Others in their field
Top investigators on “Biodistribution”
- Richard J. Whitley · University Of Alabama At Birmingham$37,499,995
- David Heimbrook · Leidos Biomedical Research, Inc.$28,845,920
- Steven H Liang · Emory University$24,468,532
- Michael Welch · Washington University$18,835,712
- Kamel Khalili · Temple University$17,758,009
- Xinhua Li · Nano Terra, Inc.$17,491,533
Research focus
BiodistributionIn VivoDoseInnovationTumorGoldRoentgen RaysBiologicalKineticsClinically RelevantRadiationRadiosensitizationIn VitroNanotechnologyMediatingRadiation TherapyTranslationsInvestigationClinical TranslationNanoparticleToxic EffectNanogoldDna Double Strand BreakComputer Models
Grant awards (18)
Rational translation of gold nanoparticle mediated radiosensitization to the clinic$624,904
R01 · FY2025 · CA
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$597,297
R01 · FY2025 · CA
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$567,432
R01 · FY2024 · CA
Rational translation of gold nanoparticle mediated radiosensitization to the clinic$147,082
R01 · FY2024 · CA
Rational translation of gold nanoparticle mediated radiosensitization to the clinic$640,366
R01 · FY2023 · CA
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$585,319
R01 · FY2023 · CA
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy$612,076
R01 · FY2022 · CA
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic$590,750
R01 · FY2022 · CA
Rational translation of gold nanoparticle mediated radiosensitization tothe clinic$631,688
R01 · FY2021 · CA
Towards in vivo imaging with benchtop x-ray fluorescence computed tomography$685,222
R01 · FY2019 · EB · contact PI
Towards in vivo imaging with benchtop x-ray fluorescence computed tomography$740,830
R01 · FY2018 · EB · contact PI
Towards in vivo imaging with benchtop x-ray fluorescence computed tomography$749,446
R01 · FY2017 · EB · contact PI
Towards in vivo imaging with benchtop x-ray fluorescence computed tomography$777,153
R01 · FY2016 · EB · contact PI
Radiation response modulation of tumors using biocongjugated gold nanoparticles$301,511
R01 · FY2015 · CA
Radiation response modulation of tumors using biocongjugated gold nanoparticles$296,563
R01 · FY2014 · CA
Radiation response modulation of tumors using biocongjugated gold nanoparticles$291,334
R01 · FY2013 · CA
Radiation response modulation of tumors using biocongjugated gold nanoparticles$314,182
R01 · FY2012 · CA
Radiation response modulation of tumors using biocongjugated gold nanoparticles$332,943
R01 · FY2011 · CA